ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,505.22
1.35%
Dow Jones
43,487.83
0.78%
Gold vs US Dollar
2,703.20
0.00%
Brent Oil
80.005
0.00%
Bitcoin
102,797.54
-1.28%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Acadia Pharmaceuticals Inc (ACAD) Share Price

ACAD Acadia Pharmaceuticals Inc

17.57
0.05 (0.29%)
18 Jan 2025 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Acadia Pharmaceuticals Inc NASDAQ:ACAD NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.05 0.29 17.57 17.00 17.68 17.89 17.35 17.73 3,180,254 01:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 726.44M -61.29M -0.3683 -47.71 2.92B
 Type  Size  Price  Time  Units 
 16 77,700 17.57 22:44:23 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ACAD News
17/01/202521:05BWAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14/01/202514:05BWAcadia Pharmaceuticals Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
30/12/202422:37PRNUSAcadia Pharmaceuticals Set to Join S&P SmallCap 600
19/12/202421:05BWAcadia Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025
16/12/202421:05BWAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/12/202421:22EDGAR2Form 8-K - Current report
11/12/202421:05BWAcadia Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million
Period
Draw mode
Data Downloads for ACAD

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Acadia Pharmaceuticals Inc Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads